KBG Corp.

KOSDAQ:A318000 Stock Report

Market Cap: ₩49.9b

KBG Past Earnings Performance

Past criteria checks 1/6

KBG's earnings have been declining at an average annual rate of -37.1%, while the Chemicals industry saw earnings growing at 6.6% annually. Revenues have been growing at an average rate of 4.8% per year. KBG's return on equity is 5.8%, and it has net margins of 10.9%.

Key information

-37.09%

Earnings growth rate

-37.73%

EPS growth rate

Chemicals Industry Growth13.95%
Revenue growth rate4.77%
Return on equity5.79%
Net Margin10.94%
Last Earnings Update30 Jun 2025

Recent past performance updates

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21
We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

Recent updates

Earnings Working Against KBG Corp.'s (KOSDAQ:318000) Share Price Following 26% Dive

Dec 06
Earnings Working Against KBG Corp.'s (KOSDAQ:318000) Share Price Following 26% Dive

The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

Aug 06
The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21
We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Mar 02
If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Feb 03
The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

Dec 29
Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

Dec 02
Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

Revenue & Expenses Breakdown

How KBG makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A318000 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2524,2692,6553,2171,241
31 Mar 2524,4653,0333,1601,137
31 Dec 2424,9153,7663,0121,232
30 Sep 2423,9604,0382,5851,062
31 Dec 2321,5894,5831,907837

Quality Earnings: A318000 has high quality earnings.

Growing Profit Margin: A318000's current net profit margins (10.9%) are lower than last year (18.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if A318000's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare A318000's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: A318000 had negative earnings growth (-37.1%) over the past year, making it difficult to compare to the Chemicals industry average (-6.3%).


Return on Equity

High ROE: A318000's Return on Equity (5.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/26 05:50
End of Day Share Price 2025/10/24 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KBG Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.